跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IN-401
首页
药物
IN-401
IN-401
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Color difference signal processing
EP 1289314 A3
申请人: THOMSON LICENSING SA
优先权: 2001
CN
EP
3 件公开
EFFICIENT METHOD FOR PREPARING PPR PROTEIN AND USE OF THE SAME
US 2022289795 A1
申请人: EDITFORCE INC
优先权: 2019
CN
US
2 件公开
Method for viewing tumor tissue located within a body cavity
US 2001055566 A1
申请人: LUIKEN M D GEORGE A
优先权: 2001
US
2 件公开
Poloxamer and poloxamine compositions for nucleic acid delivery
US 2006013883 A1
申请人: NICOL FRANCOIS
优先权: 2002
US
2 件公开
Conserved motif of hepatitis C virus E2/NS1 region
US 7371386 B2
申请人: NOVARTIS VACCINES & DIAGNOSTIC
优先权: 2006
US
2 件公开
Hydroxylated tolans and related compounds in the treatment of a cancer
US 8716355 B2
申请人: TSAI CHUN-CHE
优先权: 2008
US
2 件公开
Recombinant adenoviral vectors and applications thereof
US 2006233756 A1
申请人: ELOIT MARC
优先权: 2002
US
Optimized expression of HPV31 L1 in yeast
US 7276243 B2
申请人: MERCK & CO INC
优先权: 2005
US
Soluble rubella E1 envelope protein variants
US 2007154883 A1
申请人: UPMEIER BARBARA
优先权: 2005
US
Preparation method of Suxiaoxintong granules
CN 104688841 A
申请人: NO 6 TRADITIONAL CHINESE MEDICINE FACTORY OF TIANJ
优先权: 2013
CN
第 1 / 4 页
上一页
下一页
药物
反馈